Back to VANGUARD GROUP INC VANGUARD GROUP INC

VVOSVVOS
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in VIVOS THERAPEUTICS INC

VANGUARD GROUP INC holds 304,161 shares of VVOS (VIVOS THERAPEUTICS INC), worth $617,447 as of 2025-Q4. The position was increased (+232.6% shares).

Current Value

$617,447

Current Shares

304,161

Total Value Change

+$589,836

Total Shares Change

+293,582

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
304,161
+232.6%
$617,4470.0%$2.06
27
2025-Q3
Increased
91,461
+114.5%
$283,5290.0%$3.13
26
2025-Q2
Unchanged
42,634
0.0%
$134,7230.0%$3.28
0
2025-Q1
Increased
42,634
+303.0%
$121,5070.0%$3.11
24
2024-Q4
Unchanged
10,579
0.0%
$45,3840.0%$4.44
0
2024-Q3
First report
10,579
-
$27,6110.0%$2.70
0

Other major holders of VVOS: Schonfeld Strategic Advisors LLC, UBS Group AG, VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used